Taysha Gene Therapies shares owned by BlackRock
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $26M | 12M | 2.24 |
| 2024-03-31 | $7.5M | 2.6M | 2.87 |
| 2023-09-30 | $2.4M | 748k | 3.16 |
| 2023-06-30 | $211k | 321k | 0.66 |
| 2023-03-31 | $317k | 398k | 0.80 |
| 2022-12-31 | $1.6M | 714k | 2.26 |
| 2022-06-30 | $3.9M | 1.0M | 3.72 |
| 2021-06-30 | $63M | 3.0M | 21.21 |
| 2021-03-31 | $46M | 2.3M | 20.30 |
| 2020-12-31 | $59M | 2.2M | 26.53 |
| 2020-09-30 | $41M | 1.8M | 22.40 |